Anne Marie Falk

Array ( [id] => 5412132 [patent_doc_number] => 20090126031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS' [patent_app_type] => utility [patent_app_number] => 12/351316 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9454 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20090126031.pdf [firstpage_image] =>[orig_patent_app_number] => 12351316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6304628 [patent_doc_number] => 20100068791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SYSTEM AND METHOD FOR CONTINUOUS FERMENTATION OF ALGAE' [patent_app_type] => utility [patent_app_number] => 12/348078 [patent_app_country] => US [patent_app_date] => 2009-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3044 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068791.pdf [firstpage_image] =>[orig_patent_app_number] => 12348078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645957 [patent_doc_number] => 20100313285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation' [patent_app_type] => utility [patent_app_number] => 12/747616 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18497 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20100313285.pdf [firstpage_image] =>[orig_patent_app_number] => 12747616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264954 [patent_doc_number] => 20090117639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Neural Progenitor Cell Populations' [patent_app_type] => utility [patent_app_number] => 12/332783 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16072 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117639.pdf [firstpage_image] =>[orig_patent_app_number] => 12332783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6487626 [patent_doc_number] => 20100285585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'METHOD FOR EXTRACELLULAR MATRIX MEDIATED DIFFERENTIATION AND PROLIFERATION OF STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/746512 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9142 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285585.pdf [firstpage_image] =>[orig_patent_app_number] => 12746512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342742 [patent_doc_number] => 20090181392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Transgenic Zebrafish Models for Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/274271 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13822 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181392.pdf [firstpage_image] =>[orig_patent_app_number] => 12274271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321863 [patent_doc_number] => 20100113568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS FOR BINDING LEWIS Y ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/261736 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8505 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113568.pdf [firstpage_image] =>[orig_patent_app_number] => 12261736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807627 [patent_doc_number] => 08445279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Cultured cell construction containing spheroids of mesenchymal stem cells and utilization thereof' [patent_app_type] => utility [patent_app_number] => 12/255342 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7441 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12255342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807627 [patent_doc_number] => 08445279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Cultured cell construction containing spheroids of mesenchymal stem cells and utilization thereof' [patent_app_type] => utility [patent_app_number] => 12/255342 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7441 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12255342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5535585 [patent_doc_number] => 20090235373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'METHOD OF DELIVERY OF NUCLEIC ACIDS TO A DEVELOPING EMBRYO' [patent_app_type] => utility [patent_app_number] => 12/249452 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4814 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20090235373.pdf [firstpage_image] =>[orig_patent_app_number] => 12249452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446099 [patent_doc_number] => 20090047325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'XENOTRANSPLANT FOR CNS THERAPY' [patent_app_type] => utility [patent_app_number] => 12/248490 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047325.pdf [firstpage_image] =>[orig_patent_app_number] => 12248490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063310 [patent_doc_number] => 20110201110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'EFFICIENT METHOD FOR ESTABLISHING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/056526 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7560 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201110.pdf [firstpage_image] =>[orig_patent_app_number] => 13056526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502748 [patent_doc_number] => 20090163436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'METHODS FOR DELIVERY OF NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/197875 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27153 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163436.pdf [firstpage_image] =>[orig_patent_app_number] => 12197875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571171 [patent_doc_number] => 08337812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms' [patent_app_type] => utility [patent_app_number] => 12/230016 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 17439 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12230016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5577478 [patent_doc_number] => 20090144840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Beta-secretase enzyme compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/191950 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 31372 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20090144840.pdf [firstpage_image] =>[orig_patent_app_number] => 12191950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533580 [patent_doc_number] => 20090233368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'ALLELE SUPPRESSION' [patent_app_type] => utility [patent_app_number] => 12/188304 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 13061 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233368.pdf [firstpage_image] =>[orig_patent_app_number] => 12188304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527259 [patent_doc_number] => 20090197336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'SUPPRESSION OF POLYMORPHIC ALLELES' [patent_app_type] => utility [patent_app_number] => 12/188405 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30306 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197336.pdf [firstpage_image] =>[orig_patent_app_number] => 12188405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273557 [patent_doc_number] => 20100255580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Differentiation of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/669289 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 67688 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255580.pdf [firstpage_image] =>[orig_patent_app_number] => 12669289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404624 [patent_doc_number] => 20090239938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'PREVENTIVE/REMEDY FOR ARTERIOSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/173244 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4164 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239938.pdf [firstpage_image] =>[orig_patent_app_number] => 12173244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305713 [patent_doc_number] => 08227246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Compositions of adult disc stem cells for the treatment of degenerative disc disease' [patent_app_type] => utility [patent_app_number] => 12/216544 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 20514 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12216544 [rel_patent_id] =>[rel_patent_doc_number] =>)